These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups. Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706 [TBL] [Abstract][Full Text] [Related]
23. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385 [TBL] [Abstract][Full Text] [Related]
24. The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis. Jumaah AS; Al-Haddad HS; McAllister KA; Yasseen AA PLoS One; 2022; 17(2):e0263585. PubMed ID: 35139130 [TBL] [Abstract][Full Text] [Related]
25. Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes. Cohen SA; Turner EH; Beightol MB; Jacobson A; Gooley TA; Salipante SJ; Haraldsdottir S; Smith C; Scroggins S; Tait JF; Grady WM; Lin EH; Cohn DE; Goodfellow PJ; Arnold MW; de la Chapelle A; Pearlman R; Hampel H; Pritchard CC Gastroenterology; 2016 Sep; 151(3):440-447.e1. PubMed ID: 27302833 [TBL] [Abstract][Full Text] [Related]
26. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557 [TBL] [Abstract][Full Text] [Related]
27. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123 [TBL] [Abstract][Full Text] [Related]
28. Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features. Joehlin-Price A; Van Ziffle J; Hills NK; Ladwig N; Rabban JT; Garg K Am J Surg Pathol; 2021 Mar; 45(3):421-429. PubMed ID: 33021522 [TBL] [Abstract][Full Text] [Related]
29. DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity. Castellucci E; He T; Goldstein DY; Halmos B; Chuy J Oncologist; 2017 May; 22(5):497-502. PubMed ID: 28465371 [TBL] [Abstract][Full Text] [Related]
30. Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis. McConechy MK; Talhouk A; Leung S; Chiu D; Yang W; Senz J; Reha-Krantz LJ; Lee CH; Huntsman DG; Gilks CB; McAlpine JN Clin Cancer Res; 2016 Jun; 22(12):2865-73. PubMed ID: 26763250 [TBL] [Abstract][Full Text] [Related]
31. POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction. Li Y; Bian Y; Wang K; Wan XP BMC Med Genet; 2019 Dec; 20(1):202. PubMed ID: 31864301 [TBL] [Abstract][Full Text] [Related]
32. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes. Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564 [TBL] [Abstract][Full Text] [Related]
33. p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis. Parra-Herran C; Bassiouny D; Lerner-Ellis J; Olkhov-Mitsel E; Ismiil N; Hogen L; Vicus D; Nofech-Mozes S Am J Surg Pathol; 2019 Dec; 43(12):1591-1599. PubMed ID: 31335355 [TBL] [Abstract][Full Text] [Related]
34. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma. Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219 [TBL] [Abstract][Full Text] [Related]
35. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063 [TBL] [Abstract][Full Text] [Related]
36. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study. Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142 [TBL] [Abstract][Full Text] [Related]
38. DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden. Riggs MJ; Lin N; Wang C; Piecoro DW; Miller RW; Hampton OA; Rao M; Ueland FR; Kolesar JM PLoS One; 2020; 15(12):e0244558. PubMed ID: 33378353 [TBL] [Abstract][Full Text] [Related]
39. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors. Lee M; Eng G; Barbari SR; Deshpande V; Shcherbakova PV; Gala MK Clin Transl Gastroenterol; 2020 Mar; 11(3):e00149. PubMed ID: 32352724 [TBL] [Abstract][Full Text] [Related]